ArticleOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2016

Assessment of off-label use of denosumab 60 mg injection during the early postmarketing period using health insurance claims data.

V Hoffman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.